Info

Bio-Technology General Corp. was founded in 1980 to develop, manufacture and market novel therapeutic productsThe Company’s overall administration, licensing, human clinical studies, marketing activities, quality assurance and regulatory affairs are primarily coordinated at the Company’s headquarters in Iselin, New JerseyPre-clinical studies, research and development activities and manufacturing of the Company’s biotechnology derived products are primarily carried out through Bio-Technology General (Israel) Ltd. ("BTG-Israel"), the Company’s wholly-owned subsidiary, in a 94,000 square foot facility in Rehovot, Israel which is GLP and GMP compliant. As of February 1, 1999 the Company had 271 employees, most of whom are engaged in research, development, manufacturing, quality assurance and marketing activities, including 36 who hold Ph.D. or M.D. degreesThe Company’s research and development organization comprises 79 scientists, associates and related personnel with expertise in molecular biology, cell biology and protein chemistryThese individuals have received various undergraduate and advanced degrees at prestigious universities throughout the worldIn addition, the Company has consulting arrangements with scientists at various institutions and universities in the United States and Israel.